This study aimed to evaluate the efficacy of PRIMA-1MET in NB cell lines and to explore the roles of p53, MYCN, glutathione (GSH) and thioredoxin (TXN) systems in PRIMA-1MET efficacy and cellular response to PRIMA-1MET. The gene discussed is TXN; the disease is neuroblastoma.